Inventurus Knowledge Solutions Ltd.
IKSInformation Technology filings
We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.
Earnings calls
7 transcript(s)/analyst meet(s) served; 3 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 7 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| COVER_LETTER | 20250206 | 2023-12-31 | no | |
| UNRESOLVED | 20250806 | 2024-06-30 | no | |
| ANALYST_MEET | 20250212 | 2024-12-31 | yes | |
| ANALYST_MEET | 20260211 | 2024-12-31 | yes | |
| ANALYST_MEET | 20250522 | 2025-03-31 | yes | |
| TRANSCRIPT | 20251106 | 2025-03-31 | yes | |
| ANALYST_MEET | 20260811 | 2025-06-30 | yes | |
| DUPLICATE | 20251106 | 2025-09-30 | no | |
| ANALYST_MEET | 20260520 | 2026-03-31 | yes |
IKS
files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.
Identity
| Statement division | general |
| Scope served | consolidated |
| Panels on this page | 4 |
Market
No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.
| Last close | 1,868.30 |
| 52-week range | 1274.9 – 1937.8 |
| Return 1M | 4.32% |
| Return 3M | 9.62% |
| Return 1Y | 23.88% |
| Return 3Y | not reported for this period |
| Return 5Y | not reported for this period |
| Market capitalisation | not shown — we could not confirm it |
| Shares outstanding | not shown — we could not confirm it |
| P/E | not shown — we could not confirm it |
| P/B | not shown — we could not confirm it |
| EV/EBITDA | not shown — we could not confirm it |
Latest quarter filed — period ending 2026-06-30
In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.
| Revenue from operations | 894.00 |
| Other income | 6.00 |
| Total income | 899.00 |
| Cost of materials consumed | -0.00 |
| Purchases of stock-in-trade | 455.00 |
| Changes in inventories | 0.00 |
| Employee benefit expense | 0.00 |
| Finance costs | 10.00 |
Ownership — 2026-06-30, and the change from 2026-03-31
| Holder | Per cent | Change |
|---|---|---|
| promoter and promoter group | 0.64 | 0.00 |
| institutions foreign | 0.08 | -0.00 |
| institutions domestic | 0.07 | 0.01 |
| mutual funds | 0.03 | -0.00 |
| public | 0.34 | 0.00 |
Documents on file
| Class | Most recent | On file |
|---|---|---|
| ANALYST_MEET | 2026-03-31 | 5 |
| COVER_LETTER | 2023-12-31 | 1 |
| DUPLICATE | 2025-09-30 | 1 |
| TRANSCRIPT | 2025-03-31 | 1 |
| UNRESOLVED | 2024-06-30 | 1 |
Financial statements
Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.
Quarterly results, as filed
| Line | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 657.00 | 724.00 | 740.00 | 781.00 | 815.00 | 858.00 | 894.00 |
| Other income | 27.00 | 3.00 | 3.00 | 4.00 | 6.00 | 5.00 | 6.00 |
| Total income | 684.00 | 727.00 | 743.00 | 785.00 | 821.00 | 863.00 | 899.00 |
| Cost of materials consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Purchases of stock-in-trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 455.00 |
| Changes in inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 |
| Employee benefit expense | 383.00 | 387.00 | 396.00 | 407.00 | 406.00 | 418.00 | 0.00 |
| Finance costs | 21.00 | 21.00 | 18.00 | 16.00 | 23.00 | 13.00 | 10.00 |
| Depreciation and amortisation | 28.00 | 28.00 | 28.00 | 30.00 | 32.00 | 34.00 | 34.00 |
| Other expenses | 92.00 | 111.00 | 106.00 | 102.00 | 127.00 | 138.00 | 144.00 |
| Total expenses | 524.00 | 547.00 | 548.00 | 556.00 | 589.00 | 604.00 | 643.00 |
| Profit before exceptional items and tax | 160.00 | 180.00 | 195.00 | 229.00 | 232.00 | 258.00 | 256.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 160.00 | 180.00 | 195.00 | 229.00 | 232.00 | 258.00 | 256.00 |
| Current tax | 37.00 | 16.00 | 57.00 | 62.00 | 52.00 | 30.00 | 68.00 |
| Deferred tax | -6.00 | 16.00 | -14.00 | -15.00 | -6.00 | 17.00 | -11.00 |
| Tax expense | 30.00 | 32.00 | 43.00 | 47.00 | 46.00 | 47.00 | 57.00 |
| Profit for the period | 130.00 | 148.00 | 152.00 | 181.00 | 183.00 | 206.00 | 194.00 |
| Profit attributable to owners | — | — | — | — | — | — | 0.00 |
| Profit attributable to non-controlling interests | — | — | — | — | — | — | 0.00 |
| Other comprehensive income | 5.00 | 63.00 | 6.00 | 87.00 | 20.00 | 50.00 | 46.00 |
| Total comprehensive income | 134.00 | 211.00 | 158.00 | 268.00 | 203.00 | 256.00 | 240.00 |
| Earnings per share, basic | 7.80 | 8.88 | 9.07 | 10.81 | 10.96 | 12.31 | 11.55 |
| Earnings per share, diluted | 7.60 | 8.70 | 8.85 | 10.58 | 10.73 | 12.06 | 11.31 |
Annual results, as filed
| Line | 2025-03-31 | 2026-03-31 |
|---|---|---|
| Revenue from operations | 2,664.00 | 3,194.00 |
| Other income | 39.00 | 17.00 |
| Total income | 2,703.00 | 3,211.00 |
| Cost of materials consumed | 0.00 | 0.00 |
| Purchases of stock-in-trade | 0.00 | 0.00 |
| Changes in inventories | 1.00 | 1.00 |
| Employee benefit expense | 1,495.00 | 1,627.00 |
| Finance costs | 90.00 | 70.00 |
| Depreciation and amortisation | 113.00 | 124.00 |
| Other expenses | 399.00 | 474.00 |
| Total expenses | 2,097.00 | 2,297.00 |
| Profit before exceptional items and tax | 606.00 | 914.00 |
| Exceptional items | 0.00 | 0.00 |
| Profit before tax | 606.00 | 914.00 |
| Current tax | 125.00 | 200.00 |
| Deferred tax | -5.00 | -17.00 |
| Tax expense | 120.00 | 183.00 |
| Profit for the period | 486.00 | 722.00 |
| Other comprehensive income | 68.00 | 163.00 |
| Total comprehensive income | 554.00 | 885.00 |
| Earnings per share, basic | 29.20 | 43.12 |
| Earnings per share, diluted | 28.62 | 42.26 |
Balance sheet, as filed
| Line | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|
| Total assets | 3,052.00 | 3,606.00 | 4,268.00 |
| Non-current assets | 2,268.00 | 2,661.00 | 2,889.00 |
| Current assets | 784.00 | 946.00 | 1,378.00 |
| Property, plant and equipment | 41.00 | 42.00 | 54.00 |
| Capital work-in-progress | 5.00 | 2.00 | 0.00 |
| Goodwill | 1,197.00 | 1,244.00 | 1,326.00 |
| Other intangible assets | 552.00 | 566.00 | 562.00 |
| Inventories | 0.00 | 0.00 | 0.00 |
| Trade receivables | 532.00 | 619.00 | 564.00 |
| Cash and cash equivalents | 180.00 | 224.00 | 389.00 |
| Total equity and liabilities | 3,052.00 | 3,606.00 | 4,268.00 |
| Equity | 1,790.00 | 2,241.00 | 2,800.00 |
| Equity share capital | 17.00 | 17.00 | 17.00 |
| Other equity | 1,773.00 | 2,224.00 | 2,783.00 |
| Total liabilities | 1,262.00 | 1,366.00 | 1,468.00 |
| Non-current liabilities | 741.00 | 680.00 | 498.00 |
| Current liabilities | 521.00 | 686.00 | 970.00 |
| Borrowings, non-current | 509.00 | 419.00 | 275.00 |
| Borrowings, current | 246.00 | 222.00 | 366.00 |
| Trade payables | 76.00 | 84.00 | 149.00 |
Cash flow, as filed
| Line | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|
| Net cash from operating activities | 318.00 | 398.00 | 674.00 |
| Net cash from investing activities | 244.00 | -177.00 | -210.00 |
| Net cash from financing activities | -389.00 | -182.00 | -412.00 |
| Purchase of property, plant and equipment | 25.00 | 8.00 | 32.00 |
| Net increase in cash | 170.00 | 43.00 | 39.00 |
| con:CFO.BEFORE_TAX | 434.00 | 472.00 | 864.00 |
| con:INTEREST_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 |
| con:INTEREST_PAID.OPERATING | 0.00 | 0.00 | 0.00 |
| con:DIVIDENDS_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 |
| con:TAX_PAID.OPERATING | 116.00 | 74.00 | 190.00 |
| con:CF_OTHER.OPERATING | 0.00 | 0.00 | 0.00 |
| con:INVESTMENTS_PURCHASED | 0.00 | 146.00 | 146.00 |
| con:INVESTMENTS_SOLD | 0.00 | 0.00 | 0.00 |
| con:PPE_DISPOSALS | 1.00 | 0.00 | 1.00 |
| con:CF_INVESTING.SUBSIDIARIES_SOLD | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_ACQUIRED | 64.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_SOLD | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_ACQUIRED | 0.00 | 0.00 | 0.00 |
Who owns it
The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.
| Holder | 2024-12-19 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|
| Promoter and promoter group | 63.72 | 63.72 | 63.72 | 63.72 | 0.64 | 0.64 | 0.64 | 0.64 |
| Domestic institutions | 5.81 | 4.45 | 4.03 | 4.33 | 0.05 | 0.06 | 0.06 | 0.07 |
| Mutual funds | 1.94 | 1.92 | 1.71 | 1.93 | 0.02 | 0.03 | 0.03 | 0.03 |
| Insurance companies | 0.39 | 0.34 | 0.13 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Foreign institutions | 4.08 | 5.48 | 5.39 | 6.50 | 0.07 | 0.08 | 0.08 | 0.08 |
| Government | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
| Public | 33.43 | 33.43 | 33.70 | 33.71 | 0.34 | 0.34 | 0.34 | 0.34 |
| Non-institutional | 23.54 | 23.50 | 24.28 | 22.88 | 0.22 | 0.20 | 0.19 | 0.19 |
| Shares outstanding | 171573159 | 171573159 | 171573159 | 171573159 | 171573159 | 171573159 | 171573159 | 171573159 |
What management said
Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.
| Date | Quarter | Who spoke | |
|---|---|---|---|
| 2026-05-20 | Q4FY26 | Read the call | |
| 2025-11-06 | FYFY25 | Read the call | |
| 2025-02-12 | Q3FY25 | Read the call |
Some earlier announcements under this heading are covering letters only — no transcript was attached.
What they said about it, quarter by quarter
| Topic | FYFY25 | Q3FY25 | Q4FY26 |
|---|---|---|---|
| Capital allocation | The second vector of our execution really was around the AQuity acquisition for which we are now almost two years in. | And the reason for that? Thesecondpartofthisquestionis,whatbusinessattributebyyou,asamanagementteam, looktotrack… | There's, obviously, going to be a sixth pillar that will likely get added here if we are fortunate enough to close the transaction that we had announc… |
| Costs | One, cost-saving at company level, and second, improving the benefit to the customer, and in turn, we get our Inventurus Knowledge Solutions Limited … | Yes. SachinGupta: So,goodquestion.Thankyou.Look,firstofall,let'sallrecognizethatweareoperatinginan environme… | — |
| Debt and cash | Cash flow was also very strong in the quarter. | — | And then based on all of that, eventually, as you would note, all that has to result in cash flows. |
| Demand | Lastly, could you comment how does our pipeline, especially for the strategic large deals, look like after the closure of a few deals that we have ann… | — | Are we unnecessarily delivering too much care or are we doing too many surgeries, too many diagnostic tests when the conditions don't demand that, rig… |
| Guidance | Sir, actually, I'd like to know that one of the key things I want to know, first of all, you do not give any annual or quarterly guidance, that's fine… | Thank you, Sachin. Moderator: Thankyou.ThenextquestioncomesfromthelineofSagarDhawanfromValueQuest.Please go ahead. … | And we thought we'll be able to leverage those people to elevate the conversation to the C-suite, which took longer than we expected. |
| Margin | Happy to note, and as you might have evidenced in our Q2 financials as well, I think we're ahead of plan on that front and we're really more or less c… | 503 crores. Therearetwoexceptionalitemsinthequarter. OneofwhichisalmostRs.25crores IPO-related expense, which … | There was, obviously, a significant margin opportunity from the AQuity acquisition by transforming their operating model from a heavy human-led US-bas… |
| People | Actually, Ruchi, the way to think about it is really to look at the employee headcount on a year-on-year basis. | — | Our headcount as of March 31, 2026 is 13,331 people, of which 1,981 are clinically trained staff. |
| Pricing | And with pricing locked in for the duration of the deal, which creates a tremendous opportunity for us in terms of our core set of economics over that… | — | Our pricing model has always been outcome-based and a percentage of the customer's revenue is how we get paid. |
| Revenue growth | While I leave some of the details to Nithya, I will say that all of this has resulted in a fairly strong quarter in which we have delivered industry-l… | And the physician market is growing at about 8%. Andsowearetalkingabout$225billionTAMgrowingat8%,whichisnearlythesiz… | Just so that people know, that headcount as of March 31, 2025 was actually a bit lower, but it was about 5.3% lower at 12,661. So, our headcount has… |